|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | |||
| Interest expense from financial instruments measured at amortized cost | |||
| Net interest income from financial instruments measured at fair value through profit or loss and other | |||
| Net interest income | |||
| Other net income from financial instruments measured at fair value through profit or loss | |||
| Fee and commission income | |||
| Fee and commission expense | |||
| Net fee and commission income | |||
| Other income | |||
| Total revenues | |||
| Credit loss expense / (release) | |||
| Personnel expenses | |||
| General and administrative expenses | |||
| Depreciation, amortization and impairment of non-financial assets | |||
| Operating expenses | |||
| Operating profit / (loss) before tax | |||
| Tax expense / (benefit) | |||
| Net profit / (loss) | |||
| Net profit / (loss) attributable to non-controlling interests | |||
| Shares issued | |||
| Balance at the beginning of the year | |||
| Balance at the end of the year | |||
| Basic and diluted earnings | |||
| Net profit / (loss) attributable to shareholders |
Loading...